New Depression Findings from Campbell University School of Osteopathic Medicine Discussed (Interleukins in Major Depressive Disorder: Lessons From Autoimmune Diseases and Pathways to Clinical Translation).

This article focuses on recent research from Campbell University School of Osteopathic Medicine in Buies Creek, North Carolina, examining the role of interleukin (IL) dysregulation in Major Depressive Disorder (MDD) and its parallels with autoimmune diseases. The study highlights that a subset of MDD patients exhibit chronic, low-grade inflammation characterized by elevated pro-inflammatory interleukins (IL-6, IL-1β, IL-18) and reduced anti-inflammatory IL-10, which impacts neurobiological processes linked to depression. While MDD involves innate immune-driven inflammation, autoimmune diseases show high-grade, adaptive immune responses, suggesting shared inflammatory pathways that could inform targeted immunomodulatory treatments. The research advocates for a precision immune-psychiatry approach using biomarkers like C-reactive protein and IL-6 to identify inflammatory depression subtypes and guide therapeutic strategies, especially when standard antidepressants are ineffective. [Extracted from the article]